Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, announces the closing of its previously announced transaction with NexGel, Inc. (“NexGel”), pursuant to which NexGel acquired certain commercial and other assets related to Celularity’s biomaterials product portfolio and received an exclusive license to develop and commercialize specified products. The transaction is intended to monetize Celularity’s biomaterials portfolio while enabling it to further concentrate resources on advancing its longevity-focused therapeutic pipeline and scalable manufacturing platform.
Read the full article: Celularity Announces Closing of Transaction with NexGel //
Source: https://www.globenewswire.com/news-release/2026/04/21/3277939/0/en/celularity-announces-closing-of-transaction-with-nexgel.html